N. Patro, “A phase III randomized controlled clinical trial evaluating the efficacy and safety of naftifine 2% cream versus terbinafine 1% cream in patients with superficial fungal infection of the skin ”, Int J Res Dermatol, vol. 10, no. 4, pp. 170–176, Jun. 2024.